Trimethylammonium

Trimethylammonium

SCHEMBL810290

CC.CN(C)C.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Trimethylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118234382-A Dewatering method 赛纳塔生物有限公司 2024-06-21 CN claimed
EP-3130615-B1 GLYOXALATION OF VINYLAMIDE POLYMER SOLENIS TECHNOLOGIES CAYMAN LP (KY) 2021-03-10 EP claimed
EP-3130615-A1 GLYOXALATION OF VINYLAMIDE POLYMER BASF SE (DE) 2017-02-15 EP claimed
CN-119686157-A Composition and method for increasing wet and dry paper strength 索理思科技开曼公司 2025-03-25 CN disclosed
CN-113785029-B Composition and method for increasing wet and dry paper strength 索理思科技开曼公司 2025-01-07 CN disclosed
CN-118234382-A Dewatering method 赛纳塔生物有限公司 2024-06-21 CN disclosed
EP-3571348-B1 HIGH MOLECULAR WEIGHT TEMPORARY WET STRENGTH RESIN FOR PAPER SOLENIS TECHNOLOGIES CAYMAN LP (KY) 2024-03-06 EP disclosed
CN-113463072-B Method for chemically plating nickel or nickel alloy coating in eutectic solvent 常州大学 2023-03-21 CN disclosed
EP-3931284-A1 COMPOSITION AND METHOD FOR INCREASING WET AND DRY PAPER STRENGTH Solenis Technologies Cayman, L.P. (KY) 2022-01-05 EP disclosed
CN-113463072-A Method for chemically plating nickel or nickel alloy coating in eutectic solvent 常州大学 2021-10-01 CN disclosed
US-11028538-B2 Composition and method for increasing wet and dry paper strength SOLENIS TECHNOLOGIES, L.P. (US) 2021-06-08 US disclosed
US-20110083821-A1 GLYOXALATION OF VINYLAMIDE POLYMER THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT 2011-04-14 US disclosed
US-7875676-B2 Reacting substantially aqueous reaction mixture of a vinylamide polymer and a cellulose reactive agent to form the adduct,wherein concentration of vinylamide polymer is below, equal to or no more than 1% above a Critical Concentration of the vinylamide polymer; dry and wet strength aid for paper CIBA SPECIALTY CHEMICALS CORPORATION (US) 2011-01-25 US disclosed
EP-2215130-A2 GLYOXALATED N-VINYLAMINE BASF SE (DE) 2010-08-11 EP disclosed
US-20090126890-A1 Glyoxalated N-vinylamine THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT 2009-05-21 US disclosed
EP-2059539-A2 GLYOXALATION OF VINYLAMIDE POLYMER Ciba Holding Inc. (CH) 2009-05-20 EP disclosed
WO-2009059725-A2 GLYOXALATED POLY (N-VINYLAMINE) BASF SE (DE) 2009-05-14 WO disclosed
US-20080064819-A1 Glyoxalation of vinylamide polymer THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT 2008-03-13 US disclosed
WO-2008028865-A2 GLYOXALATION OF VINYLAMIDE POLYMER CIBA HOLDING INC. (GB) 2008-03-13 WO disclosed
EP-0276722-A2 Water soluble cross-linkable polycondensates BAYER AG (DE) 1988-08-03 EP disclosed